NP
GILD icon

NorthRock Partners’s Gilead Sciences GILD Stock Holding History

NorthRock Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$362K Buy
2,863
+347
+14% +$45.7K 0.01% 493
2026
Q1 		$351K Sell
2,516
-58
-2% -$8.12K 0.01% 486
2025
Q4 		$316K Sell
2,574
-13,144
-84% -$1.6M 0.01% 468
2025
Q3 		$1.74M Buy
15,718
+2,796
+22% +$318K 0.03% 234
2025
Q2 		$1.43M Buy
12,922
+1,290
+11% +$137K 0.04% 176
2025
Q1 		$1.3M Buy
11,632
+425
+4% +$43.9K 0.04% 169
2024
Q4 		$1.04M Buy
11,207
+920
+9% +$82.8K 0.03% 200
2024
Q3 		$862K Buy
10,287
+1,276
+14% +$97.4K 0.03% 236
2024
Q2 		$618K Sell
9,011
-264
-3% -$17.6K 0.02% 292
2024
Q1 		$679K Sell
9,275
-1,623
-15% -$125K 0.03% 278
2023
Q4 		$883K Buy
10,898
+7,082
+186% +$551K 0.04% 213
2023
Q3 		$286K Buy
3,816
+96
+3% +$7.38K 0.03% 244
2023
Q2 		$287K Sell
3,720
-470
-11% -$37.5K 0.03% 221
2023
Q1 		$348K Sell
4,190
-583
-12% -$48.3K 0.04% 198
2022
Q4 		$410K Buy
4,773
+633
+15% +$50.1K 0.05% 186
2022
Q3 		$255K Buy
4,140
+445
+12% +$28.1K 0.03% 239
2022
Q2 		$228K Buy
+3,695
New +$229K 0.02% 271
2022
Q1 		– Sell
-2,768
Closed -$201K – 347
2021
Q4 		$201K Sell
2,768
-3,554
-56% -$245K 0.02% 318
2021
Q3 		$442K Buy
6,322
+1,009
+19% +$70.9K 0.04% 169
2021
Q2 		$366K Buy
+5,313
New +$355K 0.03% 174
2020
Q3 		– Sell
-3,587
Closed -$276K – 229
2020
Q2 		$276K Buy
3,587
+632
+21% +$48.4K 0.03% 165
2020
Q1 		$221K Sell
2,955
-9,464
-76% -$654K 0.03% 176
2019
Q4 		$807K Buy
12,419
+823
+7% +$53.6K 0.09% 115
2019
Q3 		$735K Buy
+11,596
New +$758K 0.1% 95

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

NorthRock Partners's GILD Position: Q2 2026 in Review

NorthRock Partners increased its Gilead Sciences (GILD) stake by 14% in Q2 2026, buying an estimated $45.7K and bringing the position to 2,863 shares worth $362K. The position accounts for 0.01% of the portfolio, ranked #493.

NorthRock Partners first reported a position in GILD in Q3 2019 and has held it in 24 quarters since. The position peaked at $1.74M in Q3 2025. 1,784 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • NorthRock Partners held 2,863 shares of Gilead Sciences worth $362K as of Q2 2026.
  • NorthRock Partners bought 347 Gilead Sciences shares in Q2 2026, an estimated $45.7K.
  • Gilead Sciences made up 0.01% of NorthRock Partners's portfolio in Q2 2026, its #493 holding.
  • NorthRock Partners first reported a position in Gilead Sciences in Q3 2019 and has held it in 24 quarters since.
  • NorthRock Partners's Gilead Sciences position peaked at $1.74M in Q3 2025.
  • 1,784 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on NorthRock Partners's 13F filing for Q2 2026, filed 11 Aug 2026.